{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:14:12Z","timestamp":1649142852681},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s11914-008-0019-3","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T07:14:43Z","timestamp":1224054883000},"page":"108-113","source":"Crossref","is-referenced-by-count":0,"title":["New thoughts about estrogen therapy from the Women\u2019s Health Initiative"],"prefix":"10.1007","volume":"6","author":[{"given":"Marcia Gene","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,16]]},"reference":[{"key":"19_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","volume":"291","author":"A.L. Hersh","year":"2004","unstructured":"Hersh AL, Stefanick ML, Stafford RS: National use of post-menopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004, 291:47\u201353.","journal-title":"JAMA"},{"issue":"Suppl12B","key":"19_CR2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjmed.2005.09.059","volume":"118","author":"M.L. Stefanick","year":"2005","unstructured":"Stefanick ML: Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Am J Med 2005, 118(Suppl 12B):64\u201373.","journal-title":"Am J Med"},{"key":"19_CR3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4065\/70.10.978","volume":"70","author":"S. Khosla","year":"1995","unstructured":"Khosla S, Riggs BL: Treatment options for osteoporosis. Mayo Clin Proc 1995, 70:978\u2013982.","journal-title":"Mayo Clin Proc"},{"key":"19_CR4","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1001\/jama.1941.02820220007002","volume":"116","author":"F. Albright","year":"1941","unstructured":"Albright F, Smith PH, Richardson AM: Postmenopausal osteoporosis: its clinical features. JAMA 1941, 116:2465.","journal-title":"JAMA"},{"key":"19_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2362.1980.tb00033.x","volume":"10","author":"C. Christiansen","year":"1980","unstructured":"Christiansen C, Christensen MS, McNair P, et al.: Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980, 10:273\u2013279.","journal-title":"Eur J Clin Invest"},{"key":"19_CR6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(80)92592-1","volume":"2","author":"R. Lindsay","year":"1980","unstructured":"Lindsay R, Hart DM, Forrest C, Baird C: Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980, 2:1151\u20131154.","journal-title":"Lancet"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/bmj.317.7156.457","volume":"317","author":"E. Barrett-Connor","year":"1998","unstructured":"Barrett-Connor E: Hormone replacement therapy. BMJ 1998, 317:457\u2013461.","journal-title":"BMJ"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","volume":"117","author":"E.G. Lufkin","year":"1992","unstructured":"Lufkin EG, Wahner HW, O\u2019Fallon WM, et al.: Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992, 117:1\u20139.","journal-title":"Ann Intern Med"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s001980200031","volume":"13","author":"L.E. Giske","year":"2002","unstructured":"Giske LE, Hall G, Rud T, Landgren BM: The effect of 17beta-estradiol at doses of 0.5, 1 and 2 mg compared with placebo on early postmenopausal bone loss in hysterectomized women. Osteoporos Int 2002, 13:309\u2013316.","journal-title":"Osteoporos Int"},{"key":"19_CR10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199809103391104","volume":"339","author":"S.R. Cummings","year":"1998","unstructured":"Cummings SR, Browner WS, Bauer D, et al.: Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1998, 339:733\u2013738.","journal-title":"N Engl J Med"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(81)91848-1","volume":"1","author":"C. Christiansen","year":"1981","unstructured":"Christiansen C, Christensen MS, Transbol I: Bone mass in postmenopausal women after withdrawal of oestrogen\/gestagen replacement therapy. Lancet 1981, 1:459\u2013461.","journal-title":"Lancet"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archinte.162.6.665","volume":"162","author":"G.A. Greendale","year":"2002","unstructured":"Greendale GA, Espeland M, Slone S, et al.: Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Safety Follow-up Study. Arch Intern Med 2002, 162:665\u2013672.","journal-title":"Arch Intern Med"},{"key":"19_CR13","first-page":"759","volume":"63","author":"R. Lindsay","year":"1984","unstructured":"Lindsay R, Hart DM, Clark DM: The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984, 63:759\u2013763.","journal-title":"Obstet Gynecol"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(78)92402-9","volume":"1","author":"R. Lindsay","year":"1978","unstructured":"Lindsay R, Hart DM, MacLean A, et al.: Bone response to termination of oestrogen treatment. Lancet 1978, 1:1325\u20131327.","journal-title":"Lancet"},{"key":"19_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s001980170107","volume":"12","author":"F.A. Tremollieres","year":"2001","unstructured":"Tremollieres FA, Pouilles JM, Ribot C: Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women. Osteoporos Int 2001, 12:385\u2013390.","journal-title":"Osteoporos Int"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1359\/jbmr.2002.17.1.172","volume":"17","author":"H.M. Heshmati","year":"2002","unstructured":"Heshmati HM, Khosla S, Robins SP, et al.: Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res 2002, 17:172\u2013178.","journal-title":"J Bone Miner Res"},{"key":"19_CR17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","volume":"26","author":"R. Eastell","year":"2008","unstructured":"Eastell R, Adams JE, Coleman RE, et al.: Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol 2008, 26:1051\u20131057.","journal-title":"J Clin Oncol"},{"key":"19_CR18","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1359\/jbmr.2000.15.10.1965","volume":"15","author":"R. Recker","year":"2000","unstructured":"Recker R, Lappe J, Davies K, Heaney R: Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 2000, 15:1965\u20131973.","journal-title":"J Bone Miner Res"},{"key":"19_CR19","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1172\/JCI112462","volume":"77","author":"B.L. Riggs","year":"1986","unstructured":"Riggs BL, Wahner HW, Melton LJ 3rd, et al.: Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest 1986, 77:1487\u20131491.","journal-title":"J Clin Invest"},{"key":"19_CR20","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI113201","volume":"80","author":"C. Slemenda","year":"1987","unstructured":"Slemenda C, Hui SL, Longcope C, Johnston CC: Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest 1987, 80:1261\u20131269.","journal-title":"J Clin Invest"},{"key":"19_CR21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","volume":"13","author":"B.L. Riggs","year":"1998","unstructured":"Riggs BL, Khosla S, Melton LJ 3rd: A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998, 13:763\u2013773.","journal-title":"J Bone Miner Res"},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","volume":"23","author":"B.L. Riggs","year":"2002","unstructured":"Riggs BL, Khosla S, Melton LJ 3rd: Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002, 23:279\u2013302.","journal-title":"Endocr Rev"},{"key":"19_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"L.C. Hofbauer","year":"2000","unstructured":"Hofbauer LC, Khosla S, Dunstan CR, et al.: The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000, 15:2\u201312.","journal-title":"J Bone Miner Res"},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"J.E. Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, et al.: Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 2002, 288:321\u2013333.","journal-title":"JAMA"},{"key":"19_CR25","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"G.L. Anderson","year":"2004","unstructured":"Anderson GL, Limacher M, Assaf AR, et al.: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. JAMA 2004, 291:1701\u20131712.","journal-title":"JAMA"},{"key":"19_CR26","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1161\/CIRCULATIONAHA.105.594077","volume":"113","author":"S.L. Hendrix","year":"2006","unstructured":"Hendrix SL, Wassertheil-Smoller S, Johnson KC, et al.: Effects of conjugated equine estrogen on stroke in the Women\u2019s Health Initiative. Circulation 2006, 113:2425\u20132434.","journal-title":"Circulation"},{"key":"19_CR27","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinte.166.7.772","volume":"166","author":"J.D. Curb","year":"2006","unstructured":"Curb JD, Prentice RL, Bray PF, et al.: Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med 2006, 166:772\u2013780.","journal-title":"Arch Intern Med"},{"key":"19_CR28","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","volume":"295","author":"M.L. Stefanick","year":"2006","unstructured":"Stefanick ML, Anderson GL, Margolis KL, et al.: Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006, 295:1647\u20131657.","journal-title":"JAMA"},{"key":"19_CR29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1385\/ENDO:24:3:195","volume":"24","author":"S.M. Harman","year":"2004","unstructured":"Harman SM, Brinton EA, Clarkson T, et al.: Is the WHI relevant to HRT started in the perimenopause? Endocrine 2004, 24:195\u2013202.","journal-title":"Endocrine"},{"key":"19_CR30","first-page":"252","volume":"49","author":"L. Speroff","year":"2004","unstructured":"Speroff L: A clinician\u2019s review of the WHI-related literature. Int J Fertil Womens Med 2004, 49:252\u2013267.","journal-title":"Int J Fertil Womens Med"},{"key":"19_CR31","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","volume":"291","author":"S.A. Shumaker","year":"2004","unstructured":"Shumaker SA, Legault C, Kuller L, et al.: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairement in postmenopausal women: Women\u2019s Health Initiative Memory Study. JAMA 2004, 291:2947\u20132958.","journal-title":"JAMA"},{"key":"19_CR32","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","volume":"289","author":"S.A. Shumaker","year":"2003","unstructured":"Shumaker SA, Legault C, Rapp SR, et al.: Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289:2651\u20132662.","journal-title":"JAMA"},{"key":"19_CR33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","volume":"354","author":"R.D. Jackson","year":"2006","unstructured":"Jackson RD, LaCroix AZ, Gass M, et al.: Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354:669\u2013683.","journal-title":"N Engl J Med"},{"key":"19_CR34","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","volume":"356","author":"J.E. Manson","year":"2007","unstructured":"Manson JE, Allison MA, Rossouw JE, et al.: Estrogen therapy and coronary-artery calcification. N Engl J Med 2007, 356:2591\u20132602.","journal-title":"N Engl J Med"},{"key":"19_CR35","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","volume":"297","author":"J.E. Rossouw","year":"2007","unstructured":"Rossouw JE, Prentice RL, Manson JE, et al.: Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297:1465\u20131477.","journal-title":"JAMA"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-008-0019-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-008-0019-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-008-0019-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:33:44Z","timestamp":1559435624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-008-0019-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1007\/s11914-008-0019-3","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}